Seminar Series: Evolving Regulations to Facilitate Access to Cell, Tissue and Gene Therapies
As medical management moves beyond the traditional pills, tablets and injections, the arrival of new treatment modalities in the form of cells, tissues and gene therapies has gained the attention of many in the healthcare environment. While these products hold new promises and advances in medical sciences, it also poses new challenges and concerns across various stakeholders.
CoRE welcomes you to join us for a complimentary seminar by Dr Patrick Celis. With over a decade of experience in advanced therapies, he will share how health product regulations have evolved to accommodate new sciences and allow access to advanced therapies.